Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Crawl-delay: |
Title | DEKK-TEC, |
Description | DEKK-TEC utilizes government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre-cancerous lesions, and women’s health |
Keywords | Cancer treatment, hydroperoxy analogs, cancer therapies, blood brain barrier, novel cancer therapeutic agents, oncology, pharmaceuticals, metastatic stage tumors, Lee Roy Morgan, anticancer agents, investigational anticancer agent, DM-CHOC-PEN |
WebSite | dekk-tec.com |
Host IP | 107.180.40.141 |
Location | United States |
Site | Rank |
US$1,354,174
Last updated: 2023-05-14 08:56:58
dekk-tec.com has Semrush global rank of 7,816,062. dekk-tec.com has an estimated worth of US$ 1,354,174, based on its estimated Ads revenue. dekk-tec.com receives approximately 156,251 unique visitors each day. Its web server is located in United States, with IP address 107.180.40.141. According to SiteAdvisor, dekk-tec.com is safe to visit. |
Purchase/Sale Value | US$1,354,174 |
Daily Ads Revenue | US$1,251 |
Monthly Ads Revenue | US$37,501 |
Yearly Ads Revenue | US$450,003 |
Daily Unique Visitors | 10,417 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
dekk-tec.com. | A | 7199 | IP: 107.180.40.141 |
dekk-tec.com. | NS | 3600 | NS Record: ns01.domaincontrol.com. |
dekk-tec.com. | NS | 3600 | NS Record: ns02.domaincontrol.com. |
dekk-tec.com. | MX | 3600 | MX Record: 0 dekktec-com01b.mail.protection.outlook.com. |
dekk-tec.com. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
dekk-tec.com. | TXT | 3600 | TXT Record: NETORGFT9602614.onmicrosoft.com |
DEKK-TEC, INC. Home Company Profile Management Key Values Contact Us Previous Novel Therapies for the treatment of cancer. Our present objective is to continue to create and develop novel drugs and devices for the management of cancer. Our lead therapeutic agents are DM-CHOC-PEN and hydroperoxy analogs. Company Profile DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre-cancerous lesions, and women’s health issues. We have previously licensed two of our pipeline products to Biotech/Pharmaceutical companies who have successfully driven these compounds into Phase II clinical development. We also have experience with 510K devise submissions. Our present objective is to continue to create and develop new and novel drugs based on our current novel cancer therapeutic agents - DM-CHOC-PEN and hydroperoxy analogs. Industry Sector: PHARMACEUTICALS Target Market(s) |
HTTP/1.1 200 OK Date: Thu, 23 Dec 2021 04:09:07 GMT Server: Apache X-Powered-By: PHP/7.3.33 Upgrade: h2,h2c Connection: Upgrade Content-Type: text/html; charset=UTF-8 |
Domain Name: DEKK-TEC.COM Registry Domain ID: 1384406132_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2017-11-20T15:49:33Z Creation Date: 2008-01-21T19:38:52Z Registry Expiry Date: 2023-01-21T19:38:52Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:25:12Z <<< |